Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2996 approved papers, newest first · showing 1381–1440.Search instead →

  1. 12 Jun 2026· The journal of hand surgery Asian-Pacific volume· Personal / occupational dosimetry· Radiation safety
    Exploratory Study of Radiation Exposure between Image Intensifier-Equipped C-Arm and a Flat Panel Detector During Volar Plate Fixation of the Distal Radius.
    Honda Y et al.
  2. 12 Jun 2026· Technical innovations & patient support in radiation oncology· Breast / lung positioning· Therapeutic· Free full text
    Mechanically-assisted non-invasive deep inspiration breath-hold (MANIV-DIBH): A first clinical application in paediatric radiotherapy.
    Audag N et al.
  3. 11 Jun 2026· RMD open· Radiopharmaceutical QC· Radiopharmacy· Free full text
    [⁶⁸Ga]Ga-DOTA-Siglec-9 PET/CT in newly diagnosed giant cell arteritis: an inflammation-specific, treatment-responsive molecular imaging biomarker.
    Petzinna SM et al.
  4. 11 Jun 2026· Applied radiation and isotopes· Ac-225 alpha therapy· Radiopharmacy
    New measurements of the half-life of ²²⁵Ac at the NPL and IRA.
    Durán MT et al.
  5. 10 Jun 2026· IJU case reports· Ga-68 DOTATATE· Diagnostic· Free full text
    Clinical Utility of <sup>68</sup>Ga-DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report.
    Mine Y et al.
  6. 10 Jun 2026· European journal of nuclear medicine and molecular imaging· Ga-68 PSMA PET· Diagnostic
    Eryhtropoetin induced <sup>18</sup>F-PSMA-11 bone marrow sink effect.
    Maes J et al.
  7. 10 Jun 2026· Seminars in nuclear medicine· Ga-68 DOTATATE· Diagnostic· Therapeutic
    Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.
    Valizadeh P et al.
  8. 10 Jun 2026· American journal of surgery· Lu-177 DOTATATE· Therapeutic
    Outcomes of peptide receptor radionuclide therapy after progression following hepatic cytoreductive operation for neuroendocrine tumors.
    Kozuma K et al.
  9. 8 Jun 2026· Scientific reports· Breast / lung positioning· Therapeutic· Free full text
    Organ at risk sparing by non-coplanar prone breast radiotherapy on Halcyon/Ethos linacs utilizing breast couch slewing.
    Speleers B et al.
  10. 8 Jun 2026· Radiation and environmental biophysics· TLD dosimetry· QA & dosimetry
    Towards a phantom-based quantitative assessment of dose reduction and image-quality trade-offs in half- and full-rotation dental CBCT protocols: a thermoluminescent dosimetry approach with clinical insight.
    Amasya H et al.
  11. 8 Jun 2026· Annals of medicine· I-131 therapy· Therapeutic· Free full text
    Postoperative stimulated thyroglobulin and the ps-tg/TSH ratio enhance the 2025 ATA risk stratification for predicting radioiodine response in papillary thyroid carcinoma.
    Ran B et al.
  12. 8 Jun 2026· Clinical nuclear medicine· Ga-68 DOTATATE· Diagnostic
    A Masquerading Return: When Metastatic Renal Cell Carcinoma Recurs After 20 Years to Mimic a Pancreatic Neuroendocrine Tumor on Somatostatin Receptor PET Imaging.
    Sharma A et al.
  13. 6 Jun 2026· Journal of chromatography. A· Cyclotron production· Radiopharmacy
    Separation of radium and actinium in acetic acid/acetate solutions using TK101 resin.
    Kmak KN et al.
  14. 6 Jun 2026· Radiological physics and technology· Patient-specific QA· QA & dosimetry
    A cost-effective 3D-printed phantom insert for enhanced small-field patient specific quality assurance for stereotactic radiotherapy plans.
    Tayyab SM et al.
  15. 5 Jun 2026· Nanoscale advances· Cyclotron production· Radiopharmacy· Theranostic· Free full text
    Closing the loop in nanotheranostics: from <sup>124</sup>I separation to intrinsically radiolabeled platinum nanoparticles for potential PET/CT-guided photothermal therapy.
    Ghosh S et al.
  16. 5 Jun 2026· BMC medical imaging· Breast / lung positioning· Therapeutic· Free full text
    Deformable image registration accuracy: impact of user-defined parameter selection on contour propagation for deep inspiration breath-hold and free breathing breast radiotherapy.
    Knippen S et al.
  17. 5 Jun 2026· Applied radiation and isotopes· OSL dosimetry· QA & dosimetry
    Study of CW-OSL and ML characteristics of Ca₂Al₂SiO₇:Dy3+ phosphor for high dose dosimetry application.
    Patankar PR et al.
  18. 5 Jun 2026· Applied radiation and isotopes· Adaptive radiotherapy· Therapeutic
    A study on the effects of intrafractional changes in bladder volume on positional accuracy and target dosimetry in online adaptive radiotherapy for cervical cancer.
    Chi F et al.
  19. 5 Jun 2026· Oncoimmunology· SBRT delivery· Therapeutic· Free full text
    Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis.
    Vrooman TG et al.
  20. 4 Jun 2026· EJNMMI radiopharmacy and chemistry· Cyclotron production· Radiopharmacy· Free full text
    Design and development of a semi-automated solid target assembly for the indigenous production of medical radioisotopes in the PETrace-800 cyclotron.
    Kushwaha K et al.
  21. 4 Jun 2026· Journal of radiological protection· Personal / occupational dosimetry· Radiation safety
    Occupational dose attenuation and dosimetric performance of autonomous radiation protection systems in fluoroscopy: a scoping review with implications for the role of conventional lead aprons.
    Ramos-Avasola S et al.
  22. 4 Jun 2026· Applied radiation and isotopes· Cyclotron production· Radiopharmacy
    Small cyclotron production of non-carrier-added ¹⁰³Pd from electroplated Rh targets.
    Deville C et al.
  23. 4 Jun 2026· Applied radiation and isotopes· Personal / occupational dosimetry· QA & dosimetry
    CaSO₄:Tm thermoluminescent semi-spherical-shaped pellets for improved angular dependence dosimeters.
    Polo IO et al.
  24. 4 Jun 2026· Biomedical optics express· Gold-anchor fiducial markers· QA & dosimetry· Free full text
    Radiotherapy beam tracking by dual-modality injectable fiducial marker for X-ray CT and Cherenkov luminescence imaging.
    Cao X et al.
  25. 4 Jun 2026· Clinical nuclear medicine· Ga-68 DOTATATE· Diagnostic
    High Somatostatin Receptor Expression in Alveolar Soft Part Sarcoma Detected by 68 Ga-DOTATOC PET/CT.
    Gregersen T et al.
  26. 3 Jun 2026· Journal of nuclear medicine technology· Cyclotron production· Radiopharmacy
    Transforming Challenges into Training Resources: Establishing a Sustainable FDG Production System with Radiology Technologist Education.
    Yamaguchi H.
  27. 3 Jun 2026· Pharmaceuticals (Basel, Switzerland)· Cyclotron production· Theranostic
    Emerging Theranostic Radiometals (<sup>149</sup>Tb, <sup>44</sup>Sc, <sup>52</sup>Mn, <sup>203</sup>Pb, <sup>55</sup>Co)-Decay Diversity, Production Landscape, and Translational Imaging.
    Malik N et al.
  28. 3 Jun 2026· Clinical and translational radiation oncology· Breast / lung positioning· Therapeutic· Free full text
    Continuous positive airway pressure in breast cancer radiotherapy: Protocol of a prospective clinical trial.
    Van der Vorst A et al.
  29. 3 Jun 2026· Journal of medical imaging and radiation sciences· Patient-specific QA· Therapeutic· QA & dosimetry
    Dosimetric evaluation and clinical feasibility of Halcyon-E O-ring linear accelerator for single fraction coplanar stereotactic radiosurgery.
    Shahid T et al.
  30. 3 Jun 2026· European journal of nuclear medicine and molecular imaging· Lu-177 DOTATATE· Therapeutic
    Is there a role for early SSTR-targeting PRRT in GEP-NET?
    Ricciardello G et al.
  31. 3 Jun 2026· Annals of nuclear medicine· Lu-177 DOTATATE· Therapeutic
    Efficacy and safety of peptide receptor radionuclide therapy in advanced foregut and hindgut neuroendocrine tumors: a real-world experience from a single institution.
    Aggarwal P et al.
  32. 3 Jun 2026· Molecules (Basel, Switzerland)· Radiopharmaceutical QC· Radiopharmacy· Free full text
    An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin.
    Schädlich J et al.
  33. 2 Jun 2026· EJNMMI research· Ra-223· Therapeutic· Free full text
    GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer.
    Tanegashima T et al.
  34. 1 Jun 2026· EJNMMI radiopharmacy and chemistry· Cyclotron production· Radiopharmacy· Diagnostic· Free full text
    Development of an automated radiosynthesis for [<sup>68</sup>Ga]Ga-NODAGA[40Lys]-Exendin-4 in sodium acetate buffer.
    Ragot M et al.
  35. 1 Jun 2026· Radiation protection dosimetry· OSL dosimetry· Radiation safety
    Reducing the radiation exposure of physicians during computed tomography-guided biopsy using an adjustable X-ray beam angular range.
    Hasegawa H et al.
  36. 1 Jun 2026· Journal of applied clinical medical physics· Adaptive radiotherapy· QA & dosimetry· Therapeutic· Free full text
    Quantitative assessment of CBCT image quality metrics and their translation to clinical Art workflow performance in breast cancer patients.
    Kim S et al.
  37. 1 Jun 2026· Medical physics· Adaptive radiotherapy· Therapeutic· QA & dosimetry· Free full text
    Evaluating the role of plan complexity metrics in online adaptive radiotherapy for pancreatic cancer patients.
    Cavinato S et al.
  38. 1 Jun 2026· Radiography (London, England· Linac QA· QA & dosimetry
    A five-year QATrack+ dashboard for radiotherapy physics quality management: A technical note on longitudinal LINAC and HDR monitoring.
    El Mouden O et al.
  39. 1 Jun 2026· Cancer· Lu-177 PSMA· Therapeutic
    Top advances of the year: Radiopharmaceutical therapy for prostate cancer.
    Marulanda-Corzo V et al.
  40. 1 Jun 2026· Radiological physics and technology· Gold-anchor fiducial markers· QA & dosimetry
    Comparison of platinum and gold fiducial markers for prostate radiotherapy: a phantom study.
    Mihashi N et al.
  41. 1 Jun 2026· The British journal of radiology· Breast / lung positioning· QA & dosimetry
    Evaluation of patient setup accuracy using optical surface guidance in postoperative radiotherapy for patients with breast cancer after breast-conserving surgery.
    Wan B et al.
  42. 31 May 2026· Cureus· SRS / intracranial· Therapeutic· Free full text
    Brain Arteriovenous Malformations Treated With Linear Accelerator-Based Stereotactic Radiosurgery: A Single-Institution Retrospective Experience From Latin America.
    Rangel-Sarmiento V et al.
  43. 30 May 2026· European urology focus· Lu-177 PSMA· Therapeutic
    Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial.
    Kostos L et al.
  44. 30 May 2026· Clinical and translational radiation oncology· Ra-223· Therapeutic· Free full text
    Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer <i>in vitro</i> models.
    Dunne VL et al.
  45. 29 May 2026· European journal of nuclear medicine and molecular imaging· Ac-225 alpha therapy· Therapeutic· Radiopharmacy· Free full text
    <sup>211</sup>At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges.
    Levillain H et al.
  46. 29 May 2026· Advances in radiation oncology· SRS / intracranial· Therapeutic· Free full text
    Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain Metastases.
    Leng JX et al.
  47. 28 May 2026· Clinical and translational radiation oncology· MR-linac / MR-guided· Therapeutic· Diagnostic· Free full text
    Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator.
    Jamora K et al.
  48. 28 May 2026· Physica medica· In-vivo dosimetry· QA & dosimetry
    Error identification in external beam radiotherapy using diode-based in vivo dosimetry during the transition from 2D to 3DCRT in Uganda.
    Komakech I et al.
  49. 28 May 2026· Clinical and translational radiation oncology· SBRT delivery· Therapeutic· Free full text
    Oncologic outcomes and renal function preservation after stereotactic ablative body radiotherapy versus radiofrequency ablation in stage I renal cell carcinoma.
    Yoo YJ et al.
  50. 27 May 2026· Journal of cancer research and therapeutics· SBRT delivery· Therapeutic
    Expert consensus on robotic radiosurgery system for hepatocellular carcinoma.
    Qiu B et al.
  51. 27 May 2026· The world journal of men's health· Ra-223· Therapeutic
    Early Prostate-Specific Antigen Dynamics as Predictors of Treatment Response and Survival Outcomes in Patients with Castration-Resistant Prostate Cancer and Bone Metastases Undergoing Radium-223 Therapy.
    Liu HY et al.
  52. 26 May 2026· Neuro-oncology practice· SRS / intracranial· Therapeutic
    Clinical outcomes of patients with brain metastases from colorectal cancer treated with stereotactic radiosurgery.
    Bommireddy A et al.
  53. 26 May 2026· Cancer biotherapy & radiopharmaceuticals· Radiopharmaceutical QC· Therapeutic· Radiopharmacy
    Validation of Manual In-House Synthesis, Imaging, Biodistribution, and Dosimetry of Tb-161 PSMA-617 for mCRPC Patients in a Tertiary Health Care Center: A Proof-of-Concept Study.
    Thakral P et al.
  54. 25 May 2026· Clinical and translational radiation oncology· MR-linac / MR-guided· Therapeutic· Free full text
    Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.
    Eijkelenkamp H et al.
  55. 25 May 2026· Advances in radiation oncology· SRS / intracranial· Diagnostic· Free full text
    Effect of Anatomic Contextual Information on the Performance of a Convolutional Neural Network Tasked With Brain Metastasis Detection.
    Truong E et al.
  56. 23 May 2026· Annals of nuclear medicine· Ga-68 PSMA PET· Theranostic
    Baseline PSMA-ligand PET/CT as a predictive biomarker for early progression in metastatic castration-resistant prostate cancer patients undergoing [177Lu]Lu-PSMA-617 radioligand therapy.
    Mercier B et al.
  57. 22 May 2026· Bioorganic & medicinal chemistry letters· Lu-177 FAPI· Radiopharmacy· Theranostic
    A simple solid-phase approach for the synthesis of DOTA-conjugated α-ketoamide-based fibroblast activation protein-targeted ligands.
    Jozi S et al.
  58. 22 May 2026· Annals of the ICRP· Personal / occupational dosimetry· Radiation safety
    National medical occupational radiation dose monitoring in Saudi Arabia.
    Aljuaid M et al.
  59. 22 May 2026· ACS omega· Ac-225 alpha therapy· Theranostic· Free full text
    Preclinical Theranostic Study of <sup>68</sup>Ga/<sup>177</sup>Lu/<sup>225</sup>Ac-Labeled Bicyclic Peptides Targeting Nectin‑4 in Lung Cancer.
    Chen H et al.
  60. 22 May 2026· Advances in radiation oncology· Adaptive radiotherapy· Therapeutic· Free full text
    Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.
    Chelvarajah RC et al.